Teleflex Q2 revenue rises 28.9% to $570.3 million; cuts 2026 revenue outlook
Teleflex reported second-quarter 2026 revenue from continuing operations of $570.3 million, up 28.9% from the prior year, though GAAP diluted EPS fell to $0.96 from $1.54. The company cut its 2026 GAAP revenue growth and GAAP EPS guidance while raising its adjusted EPS guidance, and said it completed the sale of its OEM business and will start a $250 million accelerated share repurchase on August 7, 2026.
Key points
- Q2 2026 revenue of $570.3 million was up 28.9% reported and 4.7% on a pro forma adjusted constant currency basis; adjusted diluted EPS was $1.76 versus $1.73 a year earlier
- 2026 GAAP diluted EPS from continuing operations guidance was cut to $2.54 to $2.84; adjusted diluted EPS guidance was raised to $6.90 to $7.20
- 2026 GAAP revenue growth guidance was reduced to 13.40% to 14.40%, and pro forma adjusted constant currency growth guidance to 3.50% to 4.50%, which management attributed to a longer-than-expected integration of the Biotronik Vascular Inter
- OEM divestiture closed for $1.5 billion in cash; $700 million Term Loan A-2 was paid off, and $250 million of stock was repurchased in Q2 with a $250 million accelerated share repurchase set to begin August 7, 2026
The filing
Written by AI on Nov 8, 2026, 12:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.